PriceList for Approved Needle- Free Insulin Device - TECHiJET Q-Link – Quinovare

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

We insist on offering high-quality production with great enterprise concept, honest product sales and also the finest and fast service. it will bring you not only the superior quality solution and huge profit, but the most significant should be to occupy the endless market for Needle-Free Kit , Admelog Pen , Medical Device , We welcome buyers all around the word to make contact with us for foreseeable future small business associations. Our products and solutions are the most beneficial. Once Selected, Perfect Forever!
PriceList for Approved Needle- Free Insulin Device - TECHiJET Q-Link – Quinovare Detail:

Detail

China has entered the Big Data Era, wherein integrating data collection and data analyzing functions into product is a trend. What is data storage? Data storage refers to the use of recording media to retain data using computers or other devices. The most prevalent forms of data storage are file storage, block storage, and object storage, with each being ideal for different purposes.

At present, insurance companies take the initiative to do things that are very good in blood glucose control, and can cooperate with them to manage usage behaviors more accurately, so that insurance can have a better control expenses. That’s why Quinovare developed the new accessory: Q-Link. It is designed specifically for QS-P. It automatically record the injection dose and the injection time. This injection data can be transfer to Quinovare cloud app for further monitoring. It can also able to connect to another device for data sharing and it would be a great advantage to hospital personnel and patients because it can be combine with the hospital system to form a close loop of personal health data.

We had over 30 clinical trials about insulin with more than 50 Chinese diabetic experts, the famous one is that QS-P finished its RWL insulin clinical trial with 426 patients and it was published in Lancet Journal in 2019. It has a positive conclusion therefore using needle-free injector to inject insulin comes with great advantages, it can eliminate needle phobia, prevent skin puncture hazards and its destruction, also does not cause problem of bleeding or bruising and minimal skin response, and better medication delivery and better reproducibility as compared to invasive drug delivery systems and hence enhance bioavailability and avoids problems of reconstitution and any effect of shearing. The expert published this Journal was surprised by the needle-free injection result and make a speech in US ADA, he believed a data storage of QS-P  can save injection behavior of patients and will help diabetic doctor to offer better control of their blood sugar.


Product detail pictures:

PriceList for Approved Needle- Free Insulin Device - TECHiJET Q-Link – Quinovare detail pictures


Related Product Guide:

Our company puts emphasis on the management, the introduction of talented personnel, and the construction of staff building, trying hard to improve the quality and liability consciousness of staff members. Our company successfully attained IS9001 Certification and European CE Certification of PriceList for Approved Needle- Free Insulin Device - TECHiJET Q-Link – Quinovare , The product will supply to all over the world, such as: Oslo, Rio de Janeiro, Nepal, Furthermore, all of our products are manufactured with advanced equipment and strict QC procedures in order to ensure high quality. If you are interested in any of our products, please don't hesitate to contact us. We will do our best to meet your needs.
  • The manufacturer gave us a big discount under the premise of ensuring the quality of products, thank you very much, we will select this company again.
    5 Stars By Anna from Islamabad - 2017.02.14 13:19
    Production management mechanism is completed, quality is guaranteed, high credibility and service let the cooperation is easy, perfect!
    5 Stars By Murray from Rotterdam - 2018.10.09 19:07
    Write your message here and send it to us